The medical spa (MedSpa/MediSpa) market has expanded rapidly across the United States, driven by consumer demand for aesthetic procedures that sit somewhere between traditional beauty services and medical treatment.
MedSpas are frequently placed using standard Professional Liability or package policies that were never designed for the full scope of services being performed. In many cases, those placements are handled without healthcare specialization or a full understanding of the underlying clinical exposures.
The result is predictable: coverage gaps that do not become visible until a claim occurs.
At that point, the exposure does not stop with the insured. It extends directly to the agent in the form of Errors & Omissions (E&O) liability.
This article examines where those gaps come from, why disclosure is central to the problem, and how improper placement creates downstream E&O exposure for insurance agents.
One of the most common mistakes in placing MedSpa coverage is treating these businesses as homogenous.
They are not.
A MedSpa is defined not by a single service, but by a continuum of procedures, ranging from low-acuity cosmetic injections to higher-risk medical treatments. Two facilities may both identify as MedSpas, yet present entirely different risk profiles.
This variability is where proper placement starts to break down.
Without a healthcare-specific underwriting lens, it is easy to group services together that should be separated and evaluated independently. This is often where specialized wholesale partners add value early, by helping retail agents map services to actual risk categories before approaching the market.
At a high level, MedSpa services fall into three categories:
Botox and dermal fillers
Basic chemical peels
Non-ablative laser treatments
These are often perceived as “routine” and are widely available across providers. However, even these services carry Healthcare Professional Liability (HPL) exposure, particularly around improper administration, infection, or nerve damage.
Laser resurfacing
Microneedling with radiofrequency
Body contouring devices
These introduce device-related risks, burn exposure, and more significant bodily injury potential.
GLP-1 weight loss programs
Hormone replacement therapy (HRT)
IV therapy and wellness infusions
Platelet-rich plasma (PRP) treatments
Peptide therapy
Stem cell or regenerative therapies
This category is where generalist placements most often fail, because these services introduce complex clinical, regulatory, product-related, and off-label treatment risks that are frequently excluded, sublimited, or entirely undisclosed.
The challenge is not just identifying these categories. It is understanding how different carriers view them, how policies respond to them, and where exclusions typically apply.
That level of alignment between operations and coverage is often not achieved through generalist placement alone.
GLP-1 weight loss programs are a strong example of how quickly a MedSpa’s risk profile can evolve. A facility that originally offered Botox and fillers may later begin operating what is effectively a medically managed weight loss program involving prescription medications, ongoing patient monitoring, and longitudinal care. From an underwriting perspective, that is a materially different exposure than cosmetic injectables alone.
Similarly, peptide therapy and regenerative medicine have become increasingly common in the MedSpa space, particularly among facilities marketing anti-aging, recovery, or performance-enhancement treatments. Many of these therapies involve peptides labeled by the FDA as “research only” or “not approved for human use.” As a result, carrier appetite is extremely limited and varies significantly across the market.
Some carriers exclude peptide-related treatments entirely. Others may offer only restricted sublimits or highly manuscripted endorsements addressing peptide exposure separately from standard Healthcare Professional Liability coverage. Even among specialized healthcare markets, underwriting approaches differ considerably depending on the specific peptide therapies being administered.
This is exactly where generalist placement can become dangerous. Without understanding how carriers differentiate between GLP-1s, FDA-approved peptide therapies, non-approved compounds, and regenerative treatments, it becomes easy to create coverage gaps that are not discovered until a claim occurs.
MedSpas are required to disclose all services performed as part of the underwriting process. This is the foundation upon which coverage is granted.
If a service is not disclosed:
It may be excluded.
It may fall outside covered professional services.
It may trigger denial based on material misrepresentation.
In practice, disclosure failures are common because MedSpas:
At the same time, agents and generalist wholesale brokers often:
Finally, agents and wholesale partners who are not deeply familiar with healthcare risks may not probe far enough into:
This is where process matters. A structured intake, often guided by an HPL specialist, is what prevents incomplete submissions and downstream coverage issues.
When disclosure is incomplete or misunderstood, coverage gaps emerge in predictable ways.
This is one of the most common and most severe gaps.
For example, a MedSpa that originally disclosed Botox and fillers may later introduce GLP-1 weight loss programs, peptide therapy, PRP, or IV infusions without notifying the carrier. When a claim arises from one of those services, coverage may not apply because:
The carrier never underwrote the exposure
The procedure may fall outside covered professional services
The treatment may involve excluded compounds or therapies
From a placement perspective, this is not just a client issue. It is often a failure to establish expectations around ongoing disclosure.
Specialized wholesalers typically reinforce this upfront, making it clear that MedSpa coverage is not static and must evolve with the business.
Many Professional Liability policies available through generalist markets:
Are designed for low-acuity outpatient risks
Exclude certain aesthetic or elective procedures
Do not contemplate prescription-based or regenerative treatments
Restrict coverage involving non-FDA-approved compounds
Apply sublimits to emerging treatment categories such as peptide therapy
Even when services are disclosed, they may be:
Sublimited
Restricted by endorsement
Or carved out entirely
Knowing which markets will entertain which services is not intuitive. It requires familiarity with healthcare carriers and their appetites.
For example, some healthcare markets now separately endorse peptide therapy exposure with dedicated sublimits and highly specific definitions of what constitutes covered peptide treatment. Others exclude these services entirely. These distinctions are highly technical, but they can materially impact how a claim is handled.
MedSpas present a structural challenge because how services are delivered does not always align cleanly with how coverage is written.
In practice:
Physicians may provide limited or remote oversight
Nurse practitioners or physician assistants may prescribe and administer treatments
Registered nurses or technicians may perform procedures under delegation
Who performs the service
Under what supervision
And what the policy responds to
If coverage is not structured to reflect how services are actually delivered, gaps form between:
Many MedSpa services operate in clinical gray areas:
Off-label drug use
Emerging regenerative therapies
Peptide therapies
Non-FDA-approved devices or protocols
These exposures are frequently:
Excluded by default
Subject to strict underwriting review
Or entirely outside standard policy intent
This is where generalist placement is most likely to fail, because these services require proactive identification and negotiation with carriers.
When coverage fails, the blame quickly shifts from the policy to the placement.
The insured’s perspective is simple:
Why wasn’t this covered? Why didn’t my agent identify this exposure? How do I recover my losses?
For agents and wholesalers alike, the E&O exposure typically arises when they:
Do not fully identify all services provided by the applicant.
Rely on or do not recognize incomplete applications.
Fail to advise on disclosure requirements.
Place coverage with markets that do not align with the totality of the risk profile.
Each of these scenarios represents a preventable error stemming from a lack of specialization in healthcare-specific risks and the absence of a structured placement process.
MedSpas look deceptively simple. In reality, they are not a standard small business risk, but a healthcare exposure with:
The parallels to other emerging healthcare sectors are clear. As seen in areas like ketamine clinics and transcranial magnetic stimulation (TMS) providers, new outpatient treatment models introduce unfamiliar risks that require specialized underwriting and coverage design.
MedSpas follow the same pattern:
Generalist placement in this environment is not just suboptimal. It is dangerous.
To properly insure a MedSpa and prevent personal E&O exposure, agents must approach MedSpas as the technical and specialized healthcare risks that they are.
In practice, this often means working with partners who specialize in Healthcare Professional Liability and understand how these exposures are evaluated.
Not every wholesaler is equipped to handle MedSpa risks. Those that are must take a proactive approach and meet each of the following requirements:
Every procedure must be identified, documented, and categorized.
Coverage must be revisited whenever services change. This is not a one-time placement.
Policies must reflect how services are actually delivered, including:
Who performs services
Level of supervision
Devices used
Clinical protocols
Prescription management responsibilities
Use of FDA-approved versus non-approved compounds
Not all carriers are equipped to underwrite MedSpas. Placement often requires:
Surplus lines markets
Healthcare-specific underwriters
Manuscript endorsements
Specialized review of exposures
MedSpas are not a cosmetic risk. They are a healthcare liability exposure disguised as a retail service.
When coverage is placed without a full understanding of services and disclosure requirements:
The most important takeaway is this:
If you do not know exactly what the MedSpa is doing, you do not know whether it is fully covered. And if it is not covered, the liability does not stop with the insured.
Healthcare Professional Liability is highly specialized, and MedSpas sit at the intersection of medicine, aesthetics, and emerging treatments. Coverage must be structured deliberately to match that complexity.
Ethos works with retail insurance agents to:
Our goal is simple: to help you place coverage that holds up when it matters and protects both you and your client.